BWXT Canada’s Peterborough facility is helping with the production of commercial medical isotopes at the Darlington nuclear generating station, the company announced Thursday.

Ontario Power Generation‘s subsidiary Laurentis Energy Partners and BWXT ITG Canada Inc. (a sister company of BWXT Canada) have partnered toward the production of molybdenum-99 (Mo-99) at OPG’s Darlington nuclear generation station on the shore of Lake Ontario in Clarington, east of Toronto.

READ MORE: Soil samples for beryllium near BWXT Peterborough show no impact on environment: study

Mo-99 is a “much-needed” medical isotope used in more than 40 million procedures a year to help detect cancers and diagnose various medical conditions, BWXT states.

BWXT says over the past two years, a team of more than 100 personnel at BWXT and Laurentis designed specialized tooling at the Peterborough facility to enable the production of medical isotopes at Darlington.

To read more please visit:

https://globalnews.ca/news/7355428/bwxt-peterborough-medical-isotope/

Source: Global News